Logo
x

Search

Subscribe Now

Potential

PharmaShots Interview: Codiak BioSciences' Douglas E. Williams Shares Insight on the Potential of its Engineered Exosomes

PharmaShots Interview: Codiak BioSciences' Douglas E. Williams Shares Insight on the Potential of its Engineered Exosomes

  • April 20, 2021
Roivant to Acquire Silicon Therapeutics for ~$450M

Roivant to Acquire Silicon Therapeutics for ~$450M

  • March 1, 2021
Eli Lilly Initiates the World's First Clinical Study to Evaluate the Potential of COVID-19 Antibody Treatment in Humans

Eli Lilly Initiates the World's First Clinical Study to Evaluate the Potential of COVID-19 Antibody Treatment in Humans

  • June 2, 2020
Merck KGaA and Pfizer's Bavencio (avelumab) Demonstrates the Potential in Gestational Trophoblastic Tumors #ASCO20

Merck KGaA and Pfizer's Bavencio (avelumab) Demonstrates the Potential in Gestational Trophoblastic Tumors #ASCO20

  • June 1, 2020
Merck Collaborates with ISB to Evaluate the Mechanism of COVID-19 and to Identify Potential Prognostic Biomarkers

Merck Collaborates with ISB to Evaluate the Mechanism of COVID-19 and to Identify Potential Prognostic Biomarkers

  • April 28, 2020
Fresenius Kabi Voluntary Recalls Two Lots of Fluorouracil Injection Due to Potential for Glass Particulate

Fresenius Kabi Voluntary Recalls Two Lots of Fluorouracil Injection Due to Potential for Glass Particulate

  • July 5, 2019
Roivant to Acquire Silicon Therapeutics for ~$450M

    Roivant to Acquire Silicon Therapeutics for ~$450M

    • March 1, 2021
    Eli Lilly Signs an Exclusive Agreement with Precision BioSciences on Genome Editing Research

      Eli Lilly Signs an Exclusive Agreement with Precision BioSciences on Genome Editing Research

      • November 23, 2020
      AstraZeneca in Talks with Gilead for a Megamerger

        AstraZeneca in Talks with Gilead for a Megamerger

        • June 8, 2020
        Eli Lilly Initiates the World

          Eli Lilly Initiates the World's First Clinical Study to Evaluate the Potential of COVID-19 Antibody Treatment in Humans

          • June 2, 2020
          Merck KGaA and Pfizer

            Merck KGaA and Pfizer's Bavencio (avelumab) Demonstrates the Potential in Gestational Trophoblastic Tumors #ASCO20

            • June 1, 2020
            Merck Collaborates with ISB to Evaluate the Mechanism of COVID-19 and to Identify Potential Prognostic Biomarkers

              Merck Collaborates with ISB to Evaluate the Mechanism of COVID-19 and to Identify Potential Prognostic Biomarkers

              • April 28, 2020
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.